Skip to content

Clinical study on the effect of Xuefu Zhuyu Decoction in the treatment of coronary heart disease (Qi deficiency and blood stasis syndrome)

Clinical study on the effect of Xuefu Zhuyu Decoction in the treatment of coronary heart disease (Qi deficiency and blood stasis syndrome)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000803
Enrollment
Unknown
Registered
2026-03-30
Start date
2026-02-14
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

Control Group:Conventional western medicine treatment
Joint Group:Xuefu Zhuyu Decoction plus conventional western medicine treatment

Sponsors

Zhangzhou Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) It conforms to the diagnostic criteria of coronary heart disease formulated by the American Heart Association in 2017, and conforms to the diagnostic and curative effect criteria of traditional Chinese medicine diseases, which is differentiated as Qi deficiency and blood stasis syndrome; (2) It was the first onset of the disease; (3) 18 = Age = 80 years old; (4) The New York Heart Association classification of cardiac function was II or III; (5) All patients were informed and willing to participate in the study, and signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Acute myocardial infarction, unstable angina pectoris requiring emergency interventional therapy, or angina shock; (2) Patients with malignant tumor; (3) Patients with immune system diseases and blood system diseases; (4) Patients with liver, kidney, lung and other important organ dysfunction; (5) Allergic to the drugs used in this study; (6) Pregnant or lactating women; (7) Those who have mental disorders and cannot cooperate with diagnosis and treatment and follow-up.

Design outcomes

Primary

MeasureTime frame
Total effective rate of clinical efficacy;

Secondary

MeasureTime frame
TCM syndrome score;Cardiac function indexes;Blood lipid level;Quality of life;Incidence of adverse reactions;

Countries

China

Contacts

Public ContactLin Lin

Zhangzhou Traditional Chinese Medicine Hospital

linli198404@126.com15260508535

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026